α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
The Way Forward
Abstract
Get full access to this article
View all available purchase options and get full access to this article.
References
Information & Authors
Information
Published In
Copyright
Publication History
Disclosure
Study Funding
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical Data, Neurology Open Access, 1, 2, (2025)./doi/10.1212/WN9.0000000000000008
- CSF α-synuclein aggregation is associated with APOE ε4 and progressive cognitive decline in Alzheimer's disease, Neurobiology of Aging, 150, (9-18), (2025).https://doi.org/10.1016/j.neurobiolaging.2025.02.008
- Prodromal Parkinson’s Disease, Neurologic Clinics, 43, 2, (209-228), (2025).https://doi.org/10.1016/j.ncl.2024.12.004
- Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches, Mammalian Genome, (2025).https://doi.org/10.1007/s00335-025-10128-w
- Preparing for Parkinson’s disease prevention trials: Current progress and future directions, Journal of Parkinson’s Disease, (2025).https://doi.org/10.1177/1877718X251334050
- Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform, EMBO Molecular Medicine, (2025).https://doi.org/10.1038/s44321-025-00229-z
- Defining essential charged residues in fibril formation of a lysosomal derived N-terminal α-synuclein truncation, Nature Communications, 16, 1, (2025).https://doi.org/10.1038/s41467-025-58899-9
- Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease, Brain Communications, 7, 2, (2025).https://doi.org/10.1093/braincomms/fcaf146
- Elucidating Pathological Mechanisms and Developing Biomarkers of Parkinson's Disease, Neurology and Clinical Neuroscience, (2025).https://doi.org/10.1111/ncn3.70013
- Linking Parkinson’s disease and melanoma: the impact of copper-driven cuproptosis and related mechanisms, npj Parkinson's Disease, 11, 1, (2025).https://doi.org/10.1038/s41531-025-00928-x
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.